|
|
|
|
|
|||||||
|
Session 15
Oral Abstract Session
Neuropathogenesis Tuesday, 10 am - 12:30 pm 606-609 |
| Moderators | David Clifford, Washington Univ. Sch. of Med., St. Louis, MO and Francisco Gonzalez-Scarano, Univ. of Pennsylvania,
Philadelphia | ||
| 10:00 61. | Factors Associated with AIDS Dementia Complex B. Brew*1, M. Fulham2, and R. Garsia2 1St. Vincent's Hosp. and 2 Royal Prince Alfred Hosp., Sydney, Australia
| ||
| 10:15 62. | Relationship of Cerebrospinal Fluid (CSF) White Blood Cells (WBCs) to CSF and Systemic HIV Infection: Cross-Sectional and Longitudinal Analysis R. W. Price*1, A. Nilsson1, S. G. Deeks1, D. Verotta1, R. M. Grant1, and 2 1Univ. of California, San Francisco and 2Gladstone Inst. of Virology and Immunology, San Francisco, CA
| ||
| 10:30 63. | Expression of DC-SIGN in Cultured Microglia and in the CNS of Individuals with and without HIV Dementia (HIV-D) L. Shawver1, F. Baribaud1, R. W. Doms1, C. Pardo-Villamizar2, J. McArthur2, and F. González-Scarano1* 1Univ. of Pennsylvania, Philadelphia and 2Johns Hopkins Univ., Baltimore, MD
| ||
| 10:45 64. | Expression and Functional Analysis of CXCR4 in the Central Nervous System J. Wang* and D. Gabuzda Dana-Farber Cancer Inst., Boston, MA
| ||
| 11:00 65. | Soluble Fas in the Cerebrospinal Fluid is a Potential Marker for the Severity and Prognosis of HIV-Associated Dementia A. Towfighi*, R. Skolasky, C. St. Hillaire, K. Conant, and J. McArthur Johns Hopkins Univ. Sch. of Med., Baltimore, MD
| ||
| 11:15 66. | Differences in HIV-1 V1/V2 and V3 Populations between Blood Plasma and Cerebral Spinal Fluid Suggest at Least Partial Virologic Compartmentalization K. Ritola*, J. A. E. Nelson, K. Robertson, C. Hall, S. A. Fiscus, and R. Swanstrom Univ. of North Carolina, Chapel Hill
| ||
| 11:30 67. | Distribution of HIV env and pol Variants in CSF and Plasma of Patients with and without Antiretroviral Therapy J. K. Wong*1,2, S. Letendre1,3, T. Macaranas1, C. Ignacio1, O. A. Daly2, H. F. Guenthard4, M. C. Strain1, S. D. W. Frost1,5, S. Pillai1, B. Good1, M. Furtado7, S. Wolinsky6, I. Grant3, D. D. Richman1,2, and J. A. McCutchan1 1Univ. of California, San Diego; 2VA San Diego Healthcare System, CA; 3HNRC, San Diego, CA; 4Univ. Hosp., Zurich, Switzerland; 5Antiviral Res. Ctr., San Diego, CA; 6Northwestern Univ., Chicago, IL; and 7Applied Biosystems, Foster City, CA
| ||
| 11:45 68. | A Murine Model for HIV-Associated Dementia: An Inducible Tat Transgenic Mouse Model B. O. Kim*, Y. Liu, and J. J. He Indiana Univ. Sch. of Med., Indianapolis and Walther Cancer Inst., Indianapolis, IN
| ||
| 12:00 69. | Increasing Prevalence of Neuropathy in the Era of Highly Active Antiretroviral Therapy (HAART) C. Cherry*1, J. McArthur2, , K. Costello1, I. Woolley1, A. Mijch1, and S. Wesselingh1 1Monash Univ., Alfred Hosp., Melbourne, Victoria, Australia and 2Johns Hopkins Univ., Baltimore, MD
| ||
| 12:15 70. | An in Vitro Model of Antiretroviral Toxic Neuropathy in Dorsal Root Ganglion Sensory Neurons S. Keswani*, C. Hasan, J. McArthur, J. Griffin, and A. Hoke Johns Hopkins Univ. Sch. of Med., Baltimore, MD
|
